Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1955 3
1956 9
1957 10
1958 9
1959 8
1960 9
1961 7
1962 8
1963 22
1964 34
1965 21
1966 18
1967 33
1968 34
1969 32
1970 34
1971 40
1972 42
1973 36
1974 43
1975 32
1976 32
1977 44
1978 55
1979 69
1980 92
1981 125
1982 123
1983 128
1984 179
1985 202
1986 215
1987 250
1988 241
1989 276
1990 305
1991 307
1992 349
1993 368
1994 367
1995 441
1996 511
1997 550
1998 616
1999 726
2000 737
2001 749
2002 733
2003 783
2004 824
2005 878
2006 973
2007 1001
2008 1104
2009 1130
2010 1213
2011 1239
2012 1449
2013 1613
2014 1726
2015 1653
2016 1765
2017 1851
2018 1932
2019 1995
2020 2285
2021 2265
2022 2288
2023 2148
2024 2264
2025 2549
2026 363

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

42,689 results

Results by year

Filters applied: . Clear all
Page 1
Vancomycin.
Wilhelm MP. Wilhelm MP. Mayo Clin Proc. 1991 Nov;66(11):1165-70. doi: 10.1016/s0025-6196(12)65799-1. Mayo Clin Proc. 1991. PMID: 1943250 Review.
Vancomycin is bactericidal against most strains of staphylococci and nonenterococcal streptococci. Although rare strains of staphylococci and enterococci that are resistant to vancomycin have been reported, bacterial resistance has thus far not emerged as a major cl …
Vancomycin is bactericidal against most strains of staphylococci and nonenterococcal streptococci. Although rare strains of staphyloc …
Renaissance of vancomycin: approaches for breaking antibiotic resistance in multidrug-resistant bacteria.
Mühlberg E, Umstätter F, Kleist C, Domhan C, Mier W, Uhl P. Mühlberg E, et al. Can J Microbiol. 2020 Jan;66(1):11-16. doi: 10.1139/cjm-2019-0309. Epub 2019 Sep 23. Can J Microbiol. 2020. PMID: 31545906 Free article. Review.
For decades, the glycopeptide antibiotic vancomycin has been considered as the "last resort" treatment of severe infections caused by Gram-positive bacteria. ...As an alternative to the generation of completely new substances, novel approaches focus on structural modificat …
For decades, the glycopeptide antibiotic vancomycin has been considered as the "last resort" treatment of severe infections caused by …
The pharmacokinetic and pharmacodynamic properties of vancomycin.
Rybak MJ. Rybak MJ. Clin Infect Dis. 2006 Jan 1;42 Suppl 1:S35-9. doi: 10.1086/491712. Clin Infect Dis. 2006. PMID: 16323118 Review.
Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity for clinicians. Vancomycin is a concentration-independent antibiotic (also referred to as a "time-dependent" antibiotic), and there …
Therefore, understanding the clinical implications of the pharmacokinetic and pharmacodynamic properties of vancomycin is a necessity …
Vancomycin mimicry: towards new supramolecular antibiotics.
Flint AJ, Davis AP. Flint AJ, et al. Org Biomol Chem. 2022 Oct 12;20(39):7694-7712. doi: 10.1039/d2ob01381a. Org Biomol Chem. 2022. PMID: 36165239 Review.
Vancomycin is the best-known of the glycopeptide group antibiotics (GPAs), a family of agents which operate by binding the C-terminal deptide D-Ala-D-Ala. ...This article gives an overview of vancomycin's structure and action, surveys past work on vancomyc …
Vancomycin is the best-known of the glycopeptide group antibiotics (GPAs), a family of agents which operate by binding the C-terminal …
Vancomycin: The pendulum swings.
Scheetz MH. Scheetz MH. Am J Health Syst Pharm. 2020 May 19;77(11):810-811. doi: 10.1093/ajhp/zxaa076. Am J Health Syst Pharm. 2020. PMID: 32426842 No abstract available.
Vancomycin.
Fekety R. Fekety R. Med Clin North Am. 1982 Jan;66(1):175-181. doi: 10.1016/s0025-7125(16)31451-1. Med Clin North Am. 1982. PMID: 7038327 Review.
Used properly, vancomycin appears efficacious and can be given with safety to infants, children, and adults. Vancomycin is incompatible with many other drugs in intravenous solutions, especially chloramphenicol, adrenocorticosteroids, and methicillin....
Used properly, vancomycin appears efficacious and can be given with safety to infants, children, and adults. Vancomycin is inc …
Vancomycin.
McHenry MC, Gavan TL. McHenry MC, et al. Pediatr Clin North Am. 1983 Feb;30(1):31-47. doi: 10.1016/s0031-3955(16)34318-8. Pediatr Clin North Am. 1983. PMID: 6338468 Review. No abstract available.
Vancomycin.
Cunha BA. Cunha BA. Med Clin North Am. 1995 Jul;79(4):817-31. doi: 10.1016/s0025-7125(16)30041-4. Med Clin North Am. 1995. PMID: 7791425 Free article. Review.
Vancomycin should not be added to drug regimens for gram-positive coverage, and the empiric use of vancomycin should be discouraged to avoid the emergence of VRE. Vancomycin serum levels are no longer necessary or cost effective in most patients because va …
Vancomycin should not be added to drug regimens for gram-positive coverage, and the empiric use of vancomycin should be discou …
Vancomycin: a review.
Levine JF. Levine JF. Med Clin North Am. 1987 Nov;71(6):1135-45. doi: 10.1016/s0025-7125(16)30801-x. Med Clin North Am. 1987. PMID: 3320615 Review.
This article reviewed the past experience and updated the present data on vancomycin. In recent years, with the release of more purified preparations of vancomycin and new clinical problems facing the clinician (that is, increasing prevalence of serious methicillin- …
This article reviewed the past experience and updated the present data on vancomycin. In recent years, with the release of more purif …
A Moving Target-Vancomycin Therapeutic Monitoring.
Burns AN, Goldman JL. Burns AN, et al. J Pediatric Infect Dis Soc. 2020 Sep 17;9(4):474-478. doi: 10.1093/jpids/piaa078. J Pediatric Infect Dis Soc. 2020. PMID: 32716487 Review.
Therapeutic drug monitoring (TDM) has been a common practice to optimize efficacy and safety of vancomycin. While vancomycin trough-only TDM has widely been integrated into pediatric clinical practice since 2009, recently updated vancomycin TDM guidelines pub …
Therapeutic drug monitoring (TDM) has been a common practice to optimize efficacy and safety of vancomycin. While vancomycin t …
42,689 results
You have reached the last available page of results. Please see the User Guide for more information.